Patient Guide: A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 105 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05508867
Status: ACTIVE_NOT_RECRUITING
Condition: Hodgkin Lymphoma
Phase: PHASE2

Where You Can Participate

This study is available at 105 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Los Angeles, California
  • • Torrance, California
  • • And 102 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008) - Join Clinical Trial NCTNCT05508867

How to Join This Clinical Trial - NCTNCT05508867

Learn how to participate in this PHASE2 trial studying an investigational therapy for Hodgkin Lymphoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hodgkin Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hodgkin Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05508867 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 105 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85719 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Torrance, California 90502 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33612 - United States

Status: Contact for availability

Clinical Research Site

Lexington, Kentucky 40536 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21231 - United States

Status: Contact for availability

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: Contact for availability

Clinical Research Site

Grand Rapids, Michigan 49503 - United States

Status: Contact for availability

Clinical Research Site

New Brunswick, New Jersey 08903 - United States

Status: Contact for availability

And 95 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Hodgkin Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships